Angiotensin II
Intensive Care Medicine · 2024-02 · 50 (2) · 279-282
DOI: 10.1007/s00134-023-07290-7 ↗Kurz gefasst
Editorial in der Zeitschrift Intensive Care Medicine, online erschienen am 08.01.2024. Verfasst von Rinaldo Bellomo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, …. Hauptthemen laut MEDLINE: Angiotensin II. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia. Rinaldo.bellomo@austin.org.au.
- Department of Critical Care, University of Melbourne, Melbourne, Australia. Rinaldo.bellomo@austin.org.au.
- Data Analytics Research and Evaluation Centre, Austin Hospital, Melbourne, Australia. Rinaldo.bellomo@austin.org.au.
- Department of Intensive Care, Austin Hospital, Heidelberg, Melbourne, VIC, 3084, Australia. Rinaldo.bellomo@austin.org.au.
- Department of Intensive Care, Royal Melbourne Hospital, Melbourne, Australia. Rinaldo.bellomo@austin.org.au.
- Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany.
ORCID-Profile: Rinaldo Bellomo
Zitieren
APA
Bellomo, R., Zarbock, A., & Landoni, G. (2024). Angiotensin II. Intensive Care Medicine, 50(2), 279-282. https://doi.org/10.1007/s00134-023-07290-7
Vancouver
Bellomo R, Zarbock A, Landoni G. Angiotensin II. Intensive Care Medicine. 2024;50(2):279-282. doi:10.1007/s00134-023-07290-7
BibTeX
@article{Bellomo2024,
author = {Bellomo, Rinaldo and Zarbock, Alexander and Landoni, Giovanni},
title = {Angiotensin II},
journal = {Intensive Care Medicine},
year = {2024},
volume = {50},
number = {2},
pages = {279--282},
doi = {10.1007/s00134-023-07290-7}
}
EUVIMED